Pharmacokinetics of ZSP1273 in Participants With Hepatic Impairment

Clinical trial NCT05856513 · COMPLETED

Trial details

NCT number: NCT05856513
Sponsor: Guangdong Raynovent Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment Pharmacokinetics

Start date: 2023-06-15
Primary completion: 2023-07-04
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.